Literature DB >> 19242688

Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology.

Alexandre R Campos1, Hans Clusmann, Marec von Lehe, Pitt Niehusmann, Albert J Becker, Johannes Schramm, Horst Urbach.   

Abstract

INTRODUCTION: Dysembryoplastic neuroepithelial tumors (DNTs) are long-term epilepsy associated tumors subdivided into simple and complex variants. The purpose of this study was to relate different DNT components identified on magnetic resonance imaging (MRI) to histopathological features and to test the hypothesis that glial nodules as a histopathological feature of complex variants induce an occasional glioma misdiagnosis.
METHODS: Clinical, MRI, and histopathologic features of DNTs operated between 1988 and 2008 were reviewed.
RESULTS: From a total of 61 DNTs, 48 simple and 13 complex variants were identified. Multiple or single pseudocysts in a cortical/subcortical location with small cysts sometimes separated from the tumor represented the glioneuronal element and were found in all DNTs. FLAIR hyperintense tissue was found between pseudocysts but--in neocortical DNTs--also circumscript in deeper tumor parts. Calcification and hemorrhages in this location occurred in four of 13 complex variants, and one of these patients was also the only one with tumor growth. Patients with complex variants had earlier seizure onset, and complex variants were more often located outside the temporal lobe. Although complex variants represented a higher diagnostic challenge, misdiagnoses also occurred in simple variants. One of five of DNTs showed contrast enhancement, which varied on follow-up studies with enhancing parts becoming nonenhancing and vice versa.
CONCLUSION: The glioneuronal element is readily identifiable on MRI and should be considered to support the DNT diagnosis. Complex DNT variants have a different clinical profile and a more variable histopathological and MRI appearance; however, misdiagnoses occasionally also occur in simple variants.

Entities:  

Mesh:

Year:  2009        PMID: 19242688     DOI: 10.1007/s00234-009-0511-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  23 in total

1.  Dysembryoplastic neuroepithelial tumors: nonspecific histological forms -- a study of 40 cases.

Authors:  C Daumas-Duport; P Varlet; S Bacha; F Beuvon; P Cervera-Pierot; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

Review 2.  Preoperative evaluation for epilepsy surgery (Bonn Algorithm).

Authors:  T Kral; H Clusmann; J Urbach; J Schramm; C E Elger; M Kurthen; T Grunwald
Journal:  Zentralbl Neurochir       Date:  2002

Review 3.  Imaging of the epilepsies.

Authors:  H Urbach
Journal:  Eur Radiol       Date:  2005-01-28       Impact factor: 5.315

4.  The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Christian E Elger; Otmar D Wiestler; Johannes Schramm
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

5.  Dysembryoplastic neuroepithelial tumor. Features in 16 patients.

Authors:  A A Raymond; S F Halpin; N Alsanjari; M J Cook; N D Kitchen; D R Fish; J M Stevens; B N Harding; F Scaravilli; B Kendall
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

6.  Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections.

Authors:  Basile Pasquier; Michel Péoc'H; Blandine Fabre-Bocquentin; Lamia Bensaadi; Dominique Pasquier; Dominique Hoffmann; Philippe Kahane; Laura Tassi; Jean-François Le Bas; Alim Louis Benabid
Journal:  Epileptic Disord       Date:  2002-06       Impact factor: 1.819

7.  [An enlarging dysembryoplastic neuroepithelial tumor during a 6-year period: a case report].

Authors:  N Yamaguchi; H Ohnishi; O Tachibana; M Hasegawa; T Emori
Journal:  No Shinkei Geka       Date:  1998-12

8.  Malignant transformation of oligoastrocytoma: a case report.

Authors:  Yoshifumi Tsuboi; Masanori Kurimoto; Shoichi Nagai; Hironaga Kamiyama; Shunro Endo
Journal:  Brain Tumor Pathol       Date:  2007-11-28       Impact factor: 3.298

9.  Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.

Authors:  C Daumas-Duport; B W Scheithauer; J P Chodkiewicz; E R Laws; C Vedrenne
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

10.  Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Tuba H Sanal; Cem Tayfun
Journal:  Neuroradiology       Date:  2007-07-14       Impact factor: 2.804

View more
  25 in total

1.  Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions.

Authors:  Anna Raabe; Ann Kristin Schmitz; Katharina Pernhorst; Alexander Grote; Christian von der Brelie; Horst Urbach; Alon Friedman; Albert J Becker; Christian E Elger; Pitt Niehusmann
Journal:  Epilepsia       Date:  2012-03       Impact factor: 5.864

2.  Uncommon low-grade brain tumors.

Authors:  Thankamma Ajithkumar; Naduni Imbulgoda; Elliott Rees; Fiona Harris; Gail Horan; Amos Burke; Sarah Jefferies; Stephen Price; Justin Cross; Kieren Allinson
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

3.  Multinodular and vacuolating neuronal tumor in an adolescent with Klinefelter syndrome.

Authors:  Anne-Sophie M C Monté; Felice D'Arco; Laurens J L De Cocker
Journal:  Neuroradiology       Date:  2017-10-16       Impact factor: 2.804

Review 4.  Neuroimaging of Dilated Perivascular Spaces: From Benign and Pathologic Causes to Mimics.

Authors:  Jeffrey D Rudie; Andreas M Rauschecker; Seyed A Nabavizadeh; Suyash Mohan
Journal:  J Neuroimaging       Date:  2017-12-27       Impact factor: 2.486

5.  Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.

Authors:  Calixto-Hope G Lucas; Javier E Villanueva-Meyer; Nicholas Whipple; Nancy Ann Oberheim Bush; Tabitha Cooney; Susan Chang; Michael McDermott; Mitchel Berger; Elaine Cham; Peter P Sun; Angelica Putnam; Hong Zhou; Robert Bollo; Samuel Cheshier; Matthew M Poppe; Kar-Ming Fung; Sarah Sung; Chad Glenn; Xuemo Fan; Serguei Bannykh; Jethro Hu; Moise Danielpour; Rong Li; Elizabeth Alva; James Johnston; Jessica Van Ziffle; Courtney Onodera; Patrick Devine; James P Grenert; Julieann C Lee; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Arie Perry; David A Solomon
Journal:  Brain Pathol       Date:  2019-11-06       Impact factor: 6.508

6.  Intraventricular dysembryoplastic neuroepithelial tumor in a pediatric patient: is it the most common extracortical location for DNT?

Authors:  Ji Yuan; Nirupma Sharma; Haroon Choudhri; Ramon Figueroa; Suash Sharma
Journal:  Childs Nerv Syst       Date:  2010-10-20       Impact factor: 1.475

Review 7.  Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.

Authors:  Roberta Rudà; Lorenzo Bello; Hugues Duffau; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Atypical characteristics and behavior of dysembryoplastic neuroepithelial tumors.

Authors:  Razan Daghistani; Elka Miller; Abhaya V Kulkarni; Elysa Widjaja
Journal:  Neuroradiology       Date:  2013-01-12       Impact factor: 2.804

Review 9.  Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature.

Authors:  Hector N Aguilar; Ryan W Hung; Vivek Mehta; Trevor Kotylak
Journal:  J Radiol Case Rep       Date:  2012-10-01

10.  Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [¹¹C]methionine PET.

Authors:  Sylvain Rheims; Sebastià Rubi; Sandrine Bouvard; Emilien Bernard; Nathalie Streichenberger; Marc Guenot; Didier Le Bars; Alexander Hammers; Philippe Ryvlin
Journal:  Neuro Oncol       Date:  2014-03-05       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.